14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Dec 01, 2020 $0.0200 $0.0200 $0.0178 $0.0178 39 053
Nov 30, 2020 $0.0165 $0.0200 $0.0140 $0.0175 414 084
Nov 27, 2020 $0.0200 $0.0200 $0.0183 $0.0185 302 337
Nov 25, 2020 $0.0180 $0.0200 $0.0180 $0.0180 76 098
Nov 24, 2020 $0.0159 $0.0200 $0.0159 $0.0180 76 098
Nov 23, 2020 $0.0175 $0.0190 $0.0160 $0.0176 76 730
Nov 20, 2020 $0.0145 $0.0190 $0.0100 $0.0175 66 732
Nov 19, 2020 $0.0190 $0.0200 $0.0160 $0.0187 49 662
Nov 18, 2020 $0.0160 $0.0200 $0.0160 $0.0200 44 744
Nov 17, 2020 $0.0181 $0.0189 $0.0161 $0.0189 33 779
Nov 16, 2020 $0.0195 $0.0195 $0.0161 $0.0180 8 168
Nov 13, 2020 $0.0160 $0.0180 $0.0160 $0.0180 8 168
Nov 12, 2020 $0.0150 $0.0200 $0.0150 $0.0190 88 469
Nov 11, 2020 $0.0180 $0.0180 $0.0160 $0.0161 4 703
Nov 10, 2020 $0.0195 $0.0199 $0.0160 $0.0161 20 204
Nov 09, 2020 $0.0170 $0.0180 $0.0157 $0.0178 68 216
Nov 06, 2020 $0.0171 $0.0198 $0.0170 $0.0170 16 246
Nov 05, 2020 $0.0170 $0.0198 $0.0170 $0.0185 125 703
Nov 04, 2020 $0.0175 $0.0198 $0.0150 $0.0198 3 849 543
Nov 03, 2020 $0.0214 $0.0214 $0.0181 $0.0200 35 550
Nov 02, 2020 $0.0185 $0.0214 $0.0181 $0.0198 40 087
Oct 30, 2020 $0.0210 $0.0215 $0.0185 $0.0196 17 431
Oct 29, 2020 $0.0185 $0.0218 $0.0185 $0.0215 38 039
Oct 28, 2020 $0.0185 $0.0219 $0.0185 $0.0219 450
Oct 27, 2020 $0.0220 $0.0220 $0.0185 $0.0203 18 188
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT